[Weiguang Biological: the actual controller will be changed to the National Pharmaceutical Group to resume trading on June 5]-according to the announcement, Shenzhen Guangming SASAC, the controlling shareholder of the company, signed a cooperation agreement with China Biological. It is agreed that Guangming SASAC and China Biological will set up a joint venture company, which is 49% owned by Guangming SASAC and 51% held by China Biological. After the establishment of the joint venture company, Guangming SASAC transferred 79.947 million shares of the company to the joint venture company without compensation, accounting for 35.25% of the total share capital of the company. After the free transfer, the joint venture company became the controlling shareholder of the company, and China Biological controlled 42.5% of the shares of the company through the joint venture company and Wuhan Biological products Research Institute Co., Ltd., and became the indirect controlling shareholder of the company. the actual controller of the company was changed from Guangming SASAC to Sinopharmaceutical Group. The shares of the company resumed trading on June 5.